Difference between revisions of "Team:Central Calgary/policy"
(2 intermediate revisions by the same user not shown) | |||
Line 137: | Line 137: | ||
<img src="https://static.igem.org/mediawiki/2015/7/7e/ScarfThing.jpg" alt="CANCERSUPPORT" style="width: 25%; float: left;">The team spent time knitting scarves and brought them to a cancer support group in Calgary. Our team was deeply affected by the experience of speaking to these people who were experiencing the negative effects of chemotherapy. Many of them strongly indicated that they would choose to be taken by cancer than to undergo chemotherapy treatment again. This discussion led to several questions among Central iGEM, with the main one being: Is the outcome of this form of treatment worth the side effects? The women in the support group also shared personal stories about their battle with breast cancer, which evidently led to a very heart-felt experience for the team. | <img src="https://static.igem.org/mediawiki/2015/7/7e/ScarfThing.jpg" alt="CANCERSUPPORT" style="width: 25%; float: left;">The team spent time knitting scarves and brought them to a cancer support group in Calgary. Our team was deeply affected by the experience of speaking to these people who were experiencing the negative effects of chemotherapy. Many of them strongly indicated that they would choose to be taken by cancer than to undergo chemotherapy treatment again. This discussion led to several questions among Central iGEM, with the main one being: Is the outcome of this form of treatment worth the side effects? The women in the support group also shared personal stories about their battle with breast cancer, which evidently led to a very heart-felt experience for the team. | ||
− | <br><br> | + | <br><br><br><br><br> |
<h1>Colorectal Cancer Run</h1> | <h1>Colorectal Cancer Run</h1> | ||
Line 145: | Line 145: | ||
− | <br><br> | + | <br><br><br><br><br><br><br><br><br> |
<h1 >TELUS Spark</h1> | <h1 >TELUS Spark</h1> | ||
Line 151: | Line 151: | ||
A few of the team members did a presentation on synthetic biology for children at the Calgary’s TELUS Spark Science Centre .They explained the project to the public and received stunning feedback from visitors of all ages. Results from surveys taken at this event show that the majority would be willing to use a bacterial form of treatment instead of chemotherapy, even when taking into account the the risks of mutation. The majority also believe that this form of treatment is ethical for human use. | A few of the team members did a presentation on synthetic biology for children at the Calgary’s TELUS Spark Science Centre .They explained the project to the public and received stunning feedback from visitors of all ages. Results from surveys taken at this event show that the majority would be willing to use a bacterial form of treatment instead of chemotherapy, even when taking into account the the risks of mutation. The majority also believe that this form of treatment is ethical for human use. | ||
− | <br><br> | + | <br><br><br><br><br><br> |
<h1>Meeting with Dr. Schaffer</h1> | <h1>Meeting with Dr. Schaffer</h1> |
Latest revision as of 18:49, 2 October 2015
Policies & Practices
Safety
The Central iGEM team works incredibly hard to ensure that all team members are working in a safe environment; working with non-pathogenic E. coli.
Team members are to wear personal protective equipment - lab coats, gloves, safety goggles, close-toed shoes, and pants - when present within the lab environment. Long hair is to be tied back and our hands are to be washed before and after entering the lab. Food and drinks are strictly prohibited in our lab zone. Due to our lab being located in the back of a biology and chemistry classroom, housekeeping was a primary concern, and the lab was constantly well maintained.
A fire extinguisher, first aid kit, and eyewash station are located within close proximity to the lab bench. All students participating in Central iGEM have WHMIS training and are tested yearly.
All members of the team respected the lab and the potential dangers that were present. With awareness of the safety, and proper attention towards protocols, all procedures were performed smoothly.
All work performed in the lab, was under the constant supervision of CBE staff.
Ethics
Antiangiogenesis is a conceptually sound form of treatment. Ingestion, the method of delivery, has low risks associated with it because it is one of the least invasive treatment options available. It ensures that the bacteria will safely and simply pass through the digestive system, without risk of any remaining in the body. The possible host bacteria include lactobacillus, bifidobacterium, and bifidobacterium breve UCC2003.
Lactobacillus naturally exists in many bodily systems (ie. digestive, urinary, and genital), and bifidobacterium grows in the gastrointestinal tract (GIT) of humans. Therefore, these bacteria will not be attacked by the body’s immune system due to the commonality of these bacteria in the soma. Bifidobacterium breve UCC2003 has been tested (Ishii et al..., 2014) on mice and and has shown that, when ingested, it is able to translocate from the GI tract, to the tumour cells. It has also shown that it does not cause sepsis, as it is can only travel to the immunosuppressed region of the body- the tumour. The host mice remained healthy throughout this experiment, entailing the immune tolerance towards this bacterium, with total elimination from the body in 5 or less weeks.
Although E. Coli could be potentially harmful when introduced to the human digestive system, lactobacillus and bifidobacterium are possible bacteria to be used in the future for Central iGEM’s project. These bacteria have been proven in clinical trials (Ishii et al…, 2014) to be safe for ingestion.